Summary of Study ST001830
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001156. The data can be accessed directly via it's Project DOI: 10.21228/M88T3S This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001830 |
Study Title | Exhaustive analysis of endogenous oxPCs in APAP-treated mice. |
Study Summary | A single dose of APAP at 300 mg/kg body weight was intraperitoneally administered into eight-week-old C57BL/6J male mice. After extraction of hepatic lipids, oxPCs were analyzed by LC/HRMS/MS. All mass spectrometry raw data obtained in this study were deposited. |
Institute | Kyushu university |
Last Name | Matsuoka |
First Name | Yuta |
Address | 3-1-1 Maidashi Higashi-ku, Fukuoka, Not USCanada, 812-8582, Japan |
ymatsu1205@gmail.com | |
Phone | +81-92-642-6624 |
Submit Date | 2021-06-13 |
Raw Data Available | Yes |
Raw Data File Type(s) | mzML |
Analysis Type Detail | LC-MS |
Release Date | 2021-10-14 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001156 |
Project DOI: | doi: 10.21228/M88T3S |
Project Title: | Structural Library and Visualization of Endogenously Oxidized Phosphatidylcholines Using Mass Spectrometry-based Techniques |
Project Summary: | Although oxidized phosphatidylcholines (oxPCs) play critical roles in numerous pathological events, the type and production site(s) of endogenous oxPCs remain unknown because of the lack of related structural information and analytical methods. Herein, a library of 465 oxPCs was constructed using high-resolution mass spectrometry (HRMS)-based analytical methods and employed to detect 70 oxPCs in mice with acetaminophen-induced acute liver failure. |
Institute: | Kyushu university |
Last Name: | Matsuoka |
First Name: | Yuta |
Address: | 3-1-1 Maidashi Higashi-ku |
Email: | ymatsu1205@gmail.com |
Phone: | +81-92-642-6624 |
Subject:
Subject ID: | SU001907 |
Subject Type: | Mammal |
Subject Species: | Mus musculus |
Taxonomy ID: | 10090 |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatments | Treatment times | Air conditions |
---|---|---|---|---|
SA170005 | S2_0194 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170006 | S2_0193 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170007 | S2_0192 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170008 | S2_0195 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170009 | S2_0198 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170010 | S2_0200 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170011 | S2_0199 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170012 | S2_0191 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170013 | S2_0196 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170014 | S2_0189 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170015 | S2_0184 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170016 | S2_0183 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170017 | S2_0182 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170018 | S2_0185 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170019 | S2_0186 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170020 | S2_0201 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170021 | S2_0188 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170022 | S2_0187 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170023 | S2_0190 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170024 | S2_0197 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170025 | S2_0202 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170026 | S2_0204 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170027 | S2_0205 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170028 | S2_0203 | C57BL6J, APAP 300 mg/kg+MT 20 mg/kg | 4h | normal air |
SA170029 | S2_0160 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170030 | S2_0159 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170031 | S2_0161 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170032 | S2_0168 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170033 | S2_0158 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170034 | S2_0162 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170035 | S2_0181 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170036 | S2_0178 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170037 | S2_0177 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170038 | S2_0179 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170039 | S2_0180 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170040 | S2_0169 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170041 | S2_0157 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170042 | S2_0171 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170043 | S2_0173 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170044 | S2_0174 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170045 | S2_0175 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170046 | S2_0176 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170047 | S2_0170 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170048 | S2_0163 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170049 | S2_0172 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170050 | S2_0164 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170051 | S2_0167 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170052 | S2_0166 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170053 | S2_0165 | C57BL6J, APAP 300 mg/kg+NAC 300 mg/kg | 4h | normal air |
SA170054 | S2_0054 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170055 | S2_0053 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170056 | S2_0050 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170057 | S2_0036 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170058 | S2_0038 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170059 | S2_0039 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170060 | S2_0040 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170061 | S2_0052 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170062 | S2_0035 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170063 | S2_0031 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170064 | S2_0032 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170065 | S2_0033 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170066 | S2_0034 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170067 | S2_0041 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170068 | S2_0037 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170069 | S2_0047 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170070 | S2_0051 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170071 | S2_0042 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170072 | S2_0045 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170073 | S2_0046 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170074 | S2_0043 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170075 | S2_0044 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170076 | S2_0048 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170077 | S2_0049 | C57BL6J, APAP 300 mg/kg | 1h | normal air |
SA170078 | S2_0155 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170079 | S2_0137 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170080 | S2_0156 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170081 | S2_0147 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170082 | S2_0153 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170083 | S2_0136 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170084 | S2_0148 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170085 | S2_0149 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170086 | S2_0150 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170087 | S2_0152 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170088 | S2_0151 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170089 | S2_0154 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170090 | S2_0144 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170091 | S2_0140 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170092 | S2_0141 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170093 | S2_0139 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170094 | S2_0138 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170095 | S2_0146 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170096 | S2_0142 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170097 | S2_0143 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170098 | S2_0134 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170099 | S2_0135 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170100 | S2_0133 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170101 | S2_0145 | C57BL6J, APAP 300 mg/kg | 24h | normal air |
SA170102 | S2_0231 | C57BL6J, APAP 300 mg/kg | 2h | 18O2 air |
SA170103 | S2_0232 | C57BL6J, APAP 300 mg/kg | 2h | 18O2 air |
SA170104 | S2_0069 | C57BL6J, APAP 300 mg/kg | 2h | normal air |
Collection:
Collection ID: | CO001900 |
Collection Summary: | The animals were anesthetized with a solution of hydrochloric acid medetomidine (Kyoritsu Seiyaku Corporation, Tokyo, Japan), midazolam (Sandoz K.K., Tokyo, Japan), and butorphanol (Meiji Seika Pharma Co., Ltd., Tokyo, Japan) 1, 2, 4, 8, or 24 h after APAP administration. Mouse liver samples were collected, and the liver samples were immediately frozen in liquid nitrogen. |
Sample Type: | Liver |
Treatment:
Treatment ID: | TR001920 |
Treatment Summary: | A single dose of APAP at 300 mg/kg body weight was intraperitoneally administered into eight-week-old C57BL/6J male mice. To suppress LPO induction by APAP administration, either 300 mg/kg body weight of NAC or 20 mg/kg body weight of MT in saline was intraperitoneally injected 1 h after APAP administration. |
Sample Preparation:
Sampleprep ID: | SP001913 |
Sampleprep Summary: | Hepatic lipids were extracted from the liver samples according to the modified Bligh and Dyer method. Briefly, 1 mL of extraction solution (methanol:chloroform:water = 5:2:2) containing 100 μM dibutylhydroxytoluene, 100 μM ethylenediaminetetraacetic acid, and 100 nM PC15:0/18:1-d7 was added to a frozen tissue sample (wet weight: approx. 50 mg), and then, the sample was homogenized using a Macro Smash homogenizer. Subsequently, the extraction solutions were sonicated on ice bath for 5 min. After centrifugation (6,000 g, 10 min, 4°C), 700 µL of the supernatant was collected, and then, 235 µL chloroform and 155 µL water were added to the supernatant. The organic layer was collected in a glass tube and dried under a stream of nitrogen gas; the dried residue was dissolved in methanol (200 µL) and stored at −80 °C before performing the LC/HRMS/MS experiments. |
Combined analysis:
Analysis ID | AN002970 | AN002971 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Reversed phase | Reversed phase |
Chromatography system | Nexera LC system (Shimadzu Co., Kyoto, Japan) | Nexera LC system (Shimadzu Co., Kyoto, Japan) |
Column | Inertsil ODS-P (150 x 2.1mm,3um) | Inertsil ODS-P (150 x 2.1mm,3um) |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive Orbitrap | Thermo Q Exactive Orbitrap |
Ion Mode | POSITIVE | NEGATIVE |
Units | Normalized amount | Normalized amount |
Chromatography:
Chromatography ID: | CH002200 |
Instrument Name: | Nexera LC system (Shimadzu Co., Kyoto, Japan) |
Column Name: | Inertsil ODS-P (150 x 2.1mm,3um) |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS002760 |
Analysis ID: | AN002970 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Individual oxPCs were identified by full-scan MS/data-dependent MS/MS or parallel reaction monitoring (PRM). The ionization conditions were as follows: ionization mode = positive, sheath gas flow rate = 40 arbitrary units, auxiliary gas flow rate = 10 arbitrary units, spray voltage = 2000 V, capillary temperature = 265 °C, S-lens level = 50, and heater temperature = 425 °C. The experimental conditions for full-scan MS were as follows: resolving power = 70000, automatic gain control target = 1 × 106, trap fill time = 100 ms, scan range = m/z 120–1500. The experimental conditions for MS/MS and PRM were as follows: resolving power = 17500, automatic gain control target = 1 × 106, trap fill time = 80 ms, isolation width = ±0.6 Da, fixed first mass = m/z 80, normalized collision energy = 20 or 35 eV, intensity threshold of precursor ions for MS/MS analysis = 3100, apex trigger = 2–4 s, and dynamic exclusion = 2 s. The intensity threshold of precursor ions for MS/MS analysis and the dynamic exclusion were set to 1 × 104 and 1 s, respectively. The inclusion list contained 465 precursor ions (m/z) of oxPCs for MS/MS analysis. LC/HRMS/MS analysis was controlled using Xcalibur 4.2.47 software (Thermo Fisher Scientific). |
Ion Mode: | POSITIVE |
MS ID: | MS002761 |
Analysis ID: | AN002971 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Individual oxPCs were identified by full-scan MS/data-dependent MS/MS or parallel reaction monitoring (PRM). The ionization conditions were as follows: ionization mode = negative, sheath gas flow rate = 40 arbitrary units, auxiliary gas flow rate = 10 arbitrary units, spray voltage = 2000 V, capillary temperature = 265 °C, S-lens level = 50, and heater temperature = 425 °C. The experimental conditions for full-scan MS were as follows: resolving power = 70000, automatic gain control target = 1 × 106, trap fill time = 100 ms, scan range = m/z 120–1500. The experimental conditions for MS/MS and PRM were as follows: resolving power = 17500, automatic gain control target = 1 × 106, trap fill time = 80 ms, isolation width = ±0.6 Da, fixed first mass = m/z 80, normalized collision energy = 20 or 35 eV, intensity threshold of precursor ions for MS/MS analysis = 3100, apex trigger = 2–4 s, and dynamic exclusion = 2 s. The intensity threshold of precursor ions for MS/MS analysis and the dynamic exclusion were set to 1 × 104 and 1 s, respectively. The inclusion list contained 465 precursor ions (m/z) of oxPCs for MS/MS analysis. LC/HRMS/MS analysis was controlled using Xcalibur 4.2.47 software (Thermo Fisher Scientific). |
Ion Mode: | NEGATIVE |